Hildegard Büning, PD Michael Morgan, Axel Schambach, Juliane Schott and PD Athanasia Warnecke (from left)
Professor Schambach was awarded approximately two million euros from the European Union for his "iHEAR" project / New gene therapies shall protect children and adults from hearing loss. High accolades for a Hannover Medical School (MHH) researcher: Professor Dr. Dr. Axel Schambach was awarded the very prominent "Consolidator Grant" from the European Research Council (ERC). The award will support his research project with approximately two million euros for the next five years. The Director of the MHH Institute of Experimental Hematology will use these funds for the "iHEAR" project, which has the long-term goal to protect children and adults from hearing loss and deafness. A great number of people are afflicted with hearing loss: approximately 2-5 per 1000 children are born deaf. Additionally, around 20% of the world's population will experience hearing loss during their lives. In Germany, around 15 million people suffer from severe hearing loss and (complete) deafness.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
